ACLY Inhibition Boosts Tumor Immunity, Suppresses Liver Cancer
A groundbreaking study has unveiled a novel mechanism by which inhibiting ATP citrate lyase (ACLY) triggers a potent antitumour immune response, substantially suppressing liver cancer...